Scholastic Corporation Announces First Quarter Dividend
Get Alerts SCHL Hot Sheet
Join SI Premium – FREE
NEW YORK, July 22, 2020 /PRNewswire/ -- Scholastic Corporation (NASDAQ: SCHL) is pleased to announce that its Board of Directors today declared a quarterly cash dividend of $0.15 per share on the Company's Class A and Common Stock for the first quarter of fiscal 2021. The dividend is payable on September 15, 2020 to all shareholders of record as of the close of business on August 31, 2020.
About ScholasticFor 100 years, Scholastic Corporation (NASDAQ: SCHL) has been encouraging the personal and intellectual growth of all children, beginning with literacy. Having earned a reputation as a trusted partner to educators and families, Scholastic is the world's largest publisher and distributor of children's books, a leading provider of literacy curriculum, professional services, and classroom magazines, and a producer of educational and entertaining children's media. The Company creates and distributes bestselling books and e-books, print and technology-based learning programs for preK to grade 12, and other products and services that support children's learning and literacy, both in school and at home. With 15 international operations and exports to 165 countries, Scholastic makes quality, affordable books available to all children around the world through school-based book clubs and book fairs, classroom libraries, school and public libraries, retail, and online. Learn more at www.scholastic.com.
SCHL: Financial
View original content to download multimedia:http://www.prnewswire.com/news-releases/scholastic-corporation-announces-first-quarter-dividend-301098094.html
SOURCE Scholastic Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMERICAN FREEDOM INITIATIVE ANNOUNCES PREMIER INDEPENDENCE DAY WEEKEND CELEBRATION IN WASHINGTON, D.C.
- Smoothie King Expands Northern Footprint with 85% Growth Across Northeast and Midwest Markets Over the Last Five Years
- CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share